Encompass Health CorporationEHCNYSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank92
3Y CAGR-8.2%
5Y CAGR+6.6%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-8.2%/yr
vs +171.5%/yr prior
5Y CAGR
+6.6%/yr
Recent deceleration
Acceleration
-179.7pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 16.34% |
| Q3 2025 | -5.98% |
| Q2 2025 | -2.96% |
| Q1 2025 | 14.94% |
| Q4 2024 | 11.10% |
| Q3 2024 | -3.01% |
| Q2 2024 | 3.90% |
| Q1 2024 | -53.35% |
| Q4 2023 | 3.35% |
| Q3 2023 | 0.28% |
| Q2 2023 | 2.09% |
| Q1 2023 | 133.95% |
| Q4 2022 | 21.09% |
| Q3 2022 | -0.74% |
| Q2 2022 | -2.03% |
| Q1 2022 | -15.36% |
| Q4 2021 | 8.09% |
| Q3 2021 | -23.84% |
| Q2 2021 | 5.44% |
| Q1 2021 | 7.62% |
| Q4 2020 | 11.88% |
| Q3 2020 | 73.72% |
| Q2 2020 | -45.74% |
| Q1 2020 | 12.55% |
| Q4 2019 | -5.41% |
| Q3 2019 | 0.82% |
| Q2 2019 | -9.07% |
| Q1 2019 | 15.24% |
| Q4 2018 | -6.01% |
| Q3 2018 | -2.04% |
| Q2 2018 | 4.49% |
| Q1 2018 | 0.18% |
| Q4 2017 | 4.00% |
| Q3 2017 | 4.24% |
| Q2 2017 | -4.24% |
| Q1 2017 | 1.75% |
| Q4 2016 | -1.42% |
| Q3 2016 | -2.58% |
| Q2 2016 | 3.68% |
| Q1 2016 | 6.01% |